Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Lifecare AS (LIFE.OL)
NOK0.30
+0.02 (+5.71%)
NO OSL Healthcare Medical - Devices
Address
Ytrebygdsvegen 215 5258
Bergen, NO
Bergen, NO
CEO
Joacim Holter
Website
lifecare.no
IPO
2018-07-11
ISIN NO0013355859
Description
Based in Norway, Lifecare AS is dedicated to the research and advancement of medical sensor technology for health tracking. A key innovation is Sencell, a compact sensor designed specifically for continuously monitoring glucose levels in diabetic patients. The company, which has its corporate headquarters in Bergen, Norway, commenced operations in 2006.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
NOK0.30
+0.02 (+5.71%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
5M
Beta
-0.43
Float Shares
11.49M
Free Float %
60.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.95% | -4.23% | -8.90% | -8.23% | -91.88% | -38.60% | -96.03% | -98.17% | -98.81% | -98.37% | -98.37% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.30
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-4.43
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-96.3% Q1'26: +19,400.0% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+57.8% ★ Q1'26: +80.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-101,564.3% Q1'26: -4,347.1% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-116,046.4% Q1'26: -2,494.6% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-206.0% Q1'26: -171.9% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+295.2% Q1'26: +847.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.79× Q1'26: -0.61× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
13.09M
est: 16.10M (-18.7%)
|
3.03M
est: 5.95M (-49.1%)
|
112.0K
est: 3.00M (-96.3%)
|
5.00M
5.00M – 5.00M
+66.7% YoY
|
10.00M
10.00M – 10.00M
+100.0% YoY
|
23.00M
23.00M – 23.00M
+130.0% YoY
|
| EBITDA |
-32.10M
est: -15.69M (-104.5%)
|
-68.09M
est: -5.80M (-1,073.8%)
|
-121.97M
est: -2.92M (-4,070.3%)
|
-4.87M
-4.87M – -4.87M
-66.7% YoY
|
-9.75M
-9.75M – -9.75M
-100.0% YoY
|
-22.42M
-22.42M – -22.42M
-130.0% YoY
|
| EBIT |
-35.35M
est: -16.10M (-119.6%)
|
-73.02M
est: -5.95M (-1,127.2%)
|
-129.97M
est: -3.00M (-4,232.4%)
|
-5.00M
-5.00M – -5.00M
-66.7% YoY
|
-10.00M
-10.00M – -10.00M
-100.0% YoY
|
-23.00M
-23.00M – -23.00M
-130.0% YoY
|
| Net Income |
-35.26M
est: -168.45M (+79.1%)
|
-71.76M
est: -95.62M (+25.0%)
|
-119.53M
est: -75.58M (-58.1%)
|
-36.81M
-36.81M – -36.81M
+51.3% YoY
|
-19.16M
-19.16M – -19.16M
+47.9% YoY
|
-20.17M
-20.17M – -20.17M
-5.3% YoY
|
| SGA |
8.08M
est: 3.72B (-99.8%)
|
15.70M
est: 1.38B (-98.9%)
|
128.61M
est: 693.82M (-81.5%)
|
1.16B
1.16B – 1.16B
+66.7% YoY
|
2.31B
2.31B – 2.31B
+100.0% YoY
|
5.32B
5.32B – 5.32B
+130.0% YoY
|
| EPS |
-3.81
est: -3.34 (-14.0%)
|
-5.62
est: -1.90 (-196.3%)
|
-2.37
est: -1.50 (-58.1%)
|
-0.73
-0.73 – -0.73
+51.3% YoY
|
-0.38
-0.38 – -0.38
+47.9% YoY
|
-0.40
-0.40 – -0.40
-5.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-124.94M
OE per share TTM
-3.48
Owner's Yield
-227.55%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
269.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-44.8K
Shares Outstanding
19.09M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Joacim Holter | Chief Executive Officer & Head of Investor Relations | 3M | male |
| Petter Nielsen | Chief Financial Officer | 2M | male |
| Renete Kaarvik | Chief Financial Officer | 2M | female |
| Jo Oeding Amundstad | Managing Director of Lifecare Veterinary | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LIFE.OL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
